Search
for
Sort by
Research 181–210 of 1000+
- Enhanced Topical Delivery of Finasteride Using Glyceryl Monooleate-Based Liquid Crystalline Nanoparticles Stabilized by Cremophor Surfactants
- Inhibition of Human Steroid 5β-Reductase (AKR1D1) by Finasteride and Structure of the Enzyme-Inhibitor Complex
- A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism
- Progesterone enhances ethanol-induced modulation of mesocortical dopamine neurons: antagonism by finasteride
- A preliminary study of finasteride in Tourette syndrome
- Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss
- Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride
- Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride
- Picogram determination of finasteride in human plasma and semen by high-performance liquid chromatography with atmospheric-pressure chemical-ionization tandem mass spectrometry
- Changes in fibronectin, laminin and type IV collagen distribution relate to basement membrane restructuring during the rat vibrissa follicle hair growth cycle.
- The developmental basis of fingerprint pattern formation and variation
- Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis.
- Fibroblast Growth Factor-9 Enhances M2 Macrophage Differentiation and Attenuates Adverse Cardiac Remodeling in the Infarcted Diabetic Heart
- Finasteride 5 mg/day treatment of patterned hair loss in normo-androgenetic postmenopausal women
- Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up
- Perifollicular Fibrosis: Pathogenetic Role in Androgenetic Alopecia
- Evaluation of Sexual Function With an International Index of Erectile Function in Subjects Taking Finasteride for Androgenetic Alopecia
- A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia
- An observational retrospective evaluation of 79 young men with long-term adverse effects after use of finasteride against androgenetic alopecia
- Effect of finasteride 5 mg (Proscar) on acne and alopecia in female patients with normal serum levels of free testosterone
- Fibroblast growth factor 5-short (FGF5s) inhibits the activity of FGF5 in primary and secondary hair follicle dermal papilla cells of cashmere goats
- Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia
- Treatment of Tourette’s Syndrome With Finasteride
- Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride
- Minoxidil vs Finasteride in the Treatment of Men With Androgenetic Alopecia
- The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism
- Finasteride
- Photobiomodulation of human dermal fibroblasts in vitro: decisive role of cell culture conditions and treatment protocols on experimental outcome